Yahoo Finance

Activist investor Trian Fund Management is pushing Solventum to separate more of its businesses after the company’s $4.1 billion deal to sell its filtration unit, according to people familiar with the matter. Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Trian believes the company should separate its dental products and software businesses and focus more on its medical and surgical unit, the people said.